AxoGen News and Activities
Presence
AxoGen develops and sells medical products for peripheral nerve repair and regeneration. Its products and support services help surgeons and hospitals treat patients with nerve injuries and nerve damage.
AxoGen products and services overview:
- Nerve repair products
- Nerve protection products
- Nerve grafts
- Surgical implants
- Processing services
- Clinical support services
Revenue: ~$187 million
Employees: 450
Headquarters: Alachua, United States (USA)
AxoGen is one of the...
AxoGen is a company listed under the stock ticker AXGN (US).
AxoGen has a direct presence in 2 countries.
They are in:
- Healthcare50%
- Medical Equipment50%
Executives
View the org chart displaying its 32 main executives
Most searched biographies at AxoGen
- Michael Dale, President, Chief Executive Officer and Director
- John Johnson, Director
- Alan Levine, Director
Create your alert
to follow the executive moves at AxoGen.
Healthcare
AxoGen has 3,493 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).
Popular M&A news in Healthcare
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Freeman Health System has acquired Northwest Health (posted on June 2 2026).
- Garner Health has just announced a $100 Million fundraising (posted on May 29 2026).
Popular contacts in Healthcare
News
Press releases by AxoGen
- Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
- Axogen, Inc. Reports First Quarter 2026 Financial Results
- Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026
- Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
- Press Releases
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
- Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- Axogen Announces Proposed Public Offering of Common Stock
- Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
- Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
- View more press releases Close
Social media about AxoGen
- AxoGen on Wikipedia, Google News & Yahoo Finance
- AxoGen on LinkedIn, X (Twitter) & YouTube
